Ryder System (R)

$262.36 +5.94 (2.32%)
Market Cap 9.83B
Revenue (ttm) 12.67B
Net Income (ttm) 499.00M
EPS (ttm) N/A
PE Ratio 19.22
Forward PE 17.52
Profit Margin 3.94%
Debt to Equity Ratio 2.59
Volume 383,800
Avg Vol 395,548
Day's Range N/A - N/A
Shares Out 38.35M
Stochastic %K 36%
Beta 1.01
Analysts Sell
Price Target $297.44

Company Profile

Ryder System, Inc. operates as a logistics and transportation company worldwide. It operates through three segments: Fleet Management Solutions (FMS), Supply Chain Solutions (SCS), and Dedicated Transportation Solutions (DTS). The FMS segment offers full-service leasing and leasing with flexible maintenance options; commercial vehicle rental; maintenance services; digital and technology support services; fuel services; and fuel planning and tax reporting, cards, and monitoring services, and cent...

Industry: Rental & Leasing Services
Sector: Industrials
Phone: 305 500 3726
Address:
2333 Ponce de Leon Blvd., Suite 700, Coral Gables, United States
Estimize
Estimize Jul. 27 at 1:09 PM
Wall St is expecting 4.16 EPS for $R Q3 [Reporting 10/22 BMO] http://www.estimize.com/intro/r?chart=historical&metric_name=eps&utm_content=
0 · Reply
PenkeInvesting
PenkeInvesting Jul. 26 at 3:43 AM
Fundamental analysis of $R (RYDER SYSTEM INC) based on financial data and reported results. #R
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jul. 24 at 1:19 PM
$R Transports steady reepinggg Upgraded to 310 at Susq $CSX $UNP
0 · Reply
EarningsInsider
EarningsInsider Jul. 23 at 4:30 PM
https://www.marketbeat.com/earnings/reports/2026-7-23-ryder-system-inc-stock/ $R Ryder System Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 23 at 11:00 AM
$R Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $3.39 up 6.27% YoY • Reported revenue of $3.35B up 4.95% YoY • Ryder System, Inc. raised its full year 2026 comparable EPS guidance to a range of $14.40 to $14.80, while maintaining its 3% operating revenue growth forecast and free cash flow outlook.
0 · Reply
Estimize
Estimize Jul. 20 at 12:01 PM
Wall St is expecting 3.69 EPS for $R Q2 [Reporting 07/23 BMO] http://www.estimize.com/intro/r?chart=historical&metric_name=eps&utm_content=
0 · Reply
mz08
mz08 Jul. 16 at 4:50 PM
$LIMN $OPEN $MSFT $R
0 · Reply
IN0V8
IN0V8 Jul. 10 at 3:16 PM
$R Citigroup cuts to neutral from buy; ups PT to $280 from $276 JP Morgan raises target price to $259 from $250
0 · Reply
abman54
abman54 Jul. 9 at 2:30 PM
$R push to $275!
0 · Reply
IN0V8
IN0V8 Jul. 8 at 3:37 PM
$R Buy Stephens resumes coverage with overweight rating; target price $310
0 · Reply
Latest News on R
Ryder CEO John Diez to Address Deutsche Bank's Chicago Industrials Summit

Aug 4, 2026, 6:55 AM EDT - 4 hours ago

Ryder CEO John Diez to Address Deutsche Bank's Chicago Industrials Summit

Ryder Earns Top-10 Industry Ranking on TIME's Inaugural America's Best Companies List

Aug 3, 2026, 4:30 PM EDT - 19 hours ago

Ryder Earns Top-10 Industry Ranking on TIME's Inaugural America's Best Companies List

Ryder Marks 25 Years of Its “Top Tech” Skills Competition: Celebrating a Quarter Century of Technician Excellence Recognition

Jul 30, 2026, 4:30 PM EDT - 4 days ago

Ryder Marks 25 Years of Its “Top Tech” Skills Competition: Celebrating a Quarter Century of Technician Excellence Recognition

Ryder price target raised to $300 from $290 at Barclays

2026-07-29T09:41:01.000Z - 6 days ago

Ryder price target raised to $300 from $290 at Barclays

Ryder price target raised to $320 from $280 at Morgan Stanley

2026-07-24T14:40:23.000Z - 11 days ago

Ryder price target raised to $320 from $280 at Morgan Stanley

Ryder price target raised to $296 from $259 at JPMorgan

2026-07-24T12:46:23.000Z - 11 days ago

Ryder price target raised to $296 from $259 at JPMorgan

Ryder price target raised to $310 from $290 at Susquehanna

2026-07-24T12:36:15.000Z - 11 days ago

Ryder price target raised to $310 from $290 at Susquehanna

Ryder price target raised to $300 from $290 at Wells Fargo

2026-07-24T10:51:32.000Z - 11 days ago

Ryder price target raised to $300 from $290 at Wells Fargo

Ryder price target raised to $283 from $280 at Citi

2026-07-24T10:41:03.000Z - 11 days ago

Ryder price target raised to $283 from $280 at Citi

Ryder System Earnings Call Transcript: Q2 2026

Jul 23, 2026, 11:00 AM EDT - 12 days ago

Ryder System Earnings Call Transcript: Q2 2026

Ryder System Earnings release: Q2 2026

Jul 23, 2026, 11:00 AM EDT - 12 days ago

Ryder System Earnings release: Q2 2026

Ryder System Slides: Q2 2026

Jul 23, 2026, 11:00 AM EDT - 12 days ago

Ryder System Slides: Q2 2026

Ryder System Quarterly report: Q2 2026

Jul 23, 2026, 11:00 AM EDT - 12 days ago

Ryder System Quarterly report: Q2 2026

Ryder sees Q3 adjusted EPS $4.00-$4.20, consensus $4.18

2026-07-23T11:12:28.000Z - 12 days ago

Ryder sees Q3 adjusted EPS $4.00-$4.20, consensus $4.18

Ryder Reports Second Quarter 2026 Results

Jul 23, 2026, 6:55 AM EDT - 12 days ago

Ryder Reports Second Quarter 2026 Results

Ryder Introduces Free 60‑Day Warranty on Used Commercial Vehicles Through Year‑End

Jul 21, 2026, 6:55 AM EDT - 14 days ago

Ryder Introduces Free 60‑Day Warranty on Used Commercial Vehicles Through Year‑End

Ryder initiated with a Market Perform at Citizens

2026-07-15T08:45:09.000Z - 20 days ago

Ryder initiated with a Market Perform at Citizens

Ryder price target raised to $259 from $250 at JPMorgan

2026-07-10T12:10:16.000Z - 25 days ago

Ryder price target raised to $259 from $250 at JPMorgan

Ryder downgraded to Neutral from Buy at Citi

2026-07-10T09:50:15.000Z - 25 days ago

Ryder downgraded to Neutral from Buy at Citi

Ryder increases quarterly dividend 11% to $1.01 per share

2026-07-09T20:35:17.000Z - 25 days ago

Ryder increases quarterly dividend 11% to $1.01 per share

Ryder Increases Quarterly Cash Dividend

Jul 9, 2026, 4:30 PM EDT - 25 days ago

Ryder Increases Quarterly Cash Dividend

Ryder resumed with an Overweight at Stephens

2026-07-08T13:01:06.000Z - 27 days ago

Ryder resumed with an Overweight at Stephens

Ryder price target raised to $280 from $263 at Morgan Stanley

2026-07-06T12:10:38.000Z - 4 weeks ago

Ryder price target raised to $280 from $263 at Morgan Stanley

Ryder price target raised to $290 from $250 at Barclays

2026-06-25T11:26:23.000Z - 5 weeks ago

Ryder price target raised to $290 from $250 at Barclays

Dr. Christina Rahm and DRC Ventures Accept Prestigious Gold Stevie(R) Award for Patent-Driven Manufacturing Innovation

Jun 24, 2026, 1:20 PM EDT - 5 weeks ago

Dr. Christina Rahm and DRC Ventures Accept Prestigious Gold Stevie(R) Award for Patent-Driven Manufacturing Innovation

Ryder to Release Second Quarter 2026 Earnings on July 23, 2026

Jun 23, 2026, 6:55 AM EDT - 6 weeks ago

Ryder to Release Second Quarter 2026 Earnings on July 23, 2026

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

Jun 17, 2026, 10:55 AM EDT - 6 weeks ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

Ryder Names 54th Annual Drivers of the Year: Celebrating Leadership on the Road and Beyond

Jun 17, 2026, 6:55 AM EDT - 6 weeks ago

Ryder Names 54th Annual Drivers of the Year: Celebrating Leadership on the Road and Beyond

Ryder price target raised to $290 from $253 at Baird

2026-06-17T10:16:13.000Z - 6 weeks ago

Ryder price target raised to $290 from $253 at Baird

Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany

Jun 15, 2026, 1:01 AM EDT - 7 weeks ago

Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany

BioInvent's TNFR2 Antibody BI-1808 Delivers Meaningful Responses and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026)

Jun 11, 2026, 2:15 AM EDT - 7 weeks ago

BioInvent's TNFR2 Antibody BI-1808 Delivers Meaningful Responses and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026)

Ryder System Transcript: 16th Annual Wells Fargo Industrials & Materials Conference

Jun 10, 2026, 12:00 PM EDT - 7 weeks ago

Ryder System Transcript: 16th Annual Wells Fargo Industrials & Materials Conference

PTOP Secures Largest Enterprise Opportunity in Company History With BostonApartments.com(R) - Here is How It Will Operate

Jun 10, 2026, 10:30 AM EDT - 7 weeks ago

PTOP Secures Largest Enterprise Opportunity in Company History With BostonApartments.com(R) - Here is How It Will Operate

Ryder Named to America's Greatest Workplaces List by Newsweek

Jun 10, 2026, 10:30 AM EDT - 7 weeks ago

Ryder Named to America's Greatest Workplaces List by Newsweek

Volt Carbon Receives U.S. Trademark Registrations for GRAPHFLAKE(R) and GRAFLAKE(R)

Jun 9, 2026, 8:16 AM EDT - 2 months ago

Volt Carbon Receives U.S. Trademark Registrations for GRAPHFLAKE(R) and GRAFLAKE(R)

Dr. Christina Rahm and The ROOT Brands Celebrate Dual Gold Stevie(R) Awards in New York City

Jun 8, 2026, 5:57 PM EDT - 2 months ago

Dr. Christina Rahm and The ROOT Brands Celebrate Dual Gold Stevie(R) Awards in New York City

Adios(R) Sells More Than 10,000 Units at High Tide Festival, Validating Festival-Driven Growth Strategy and Accelerating Retail Expansion

Jun 8, 2026, 10:05 AM EDT - 2 months ago

Adios(R) Sells More Than 10,000 Units at High Tide Festival, Validating Festival-Driven Growth Strategy and Accelerating Retail Expansion

Ryder price target raised to $290 from $260 at Wells Fargo

2026-06-05T10:40:55.000Z - 2 months ago

Ryder price target raised to $290 from $260 at Wells Fargo

Ryder CEO John Diez to Address Wells Fargo 16th Industrials & Materials Conference

Jun 3, 2026, 6:55 AM EDT - 2 months ago

Ryder CEO John Diez to Address Wells Fargo 16th Industrials & Materials Conference

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

SBFM

Core Critical Approved for Listing on OTCQB(R) Venture Market

May 29, 2026, 7:30 PM EDT - 2 months ago

Core Critical Approved for Listing on OTCQB(R) Venture Market

Theralase(R) Releases Q1 2026 Financial Statements

May 29, 2026, 5:03 PM EDT - 2 months ago

Theralase(R) Releases Q1 2026 Financial Statements

New phase III Translational Data Show DiviTum(R) TKa Captures Treatment-Specific Biological Response in Metastatic Breast Cancer

May 28, 2026, 2:50 AM EDT - 2 months ago

New phase III Translational Data Show DiviTum(R) TKa Captures Treatment-Specific Biological Response in Metastatic Breast Cancer

Totec Resources Approved for Listing on OTCQB(R) Venture Market

May 27, 2026, 4:01 PM EDT - 2 months ago

Totec Resources Approved for Listing on OTCQB(R) Venture Market

HigherVisibility Introduces Targeted Growth System(R) for Brands Competing in AI Search

May 27, 2026, 8:50 AM EDT - 2 months ago

HigherVisibility Introduces Targeted Growth System(R) for Brands Competing in AI Search

Ryder Earns VETS Indexes 3 Star Employer Award for 2026

May 27, 2026, 6:55 AM EDT - 2 months ago

Ryder Earns VETS Indexes 3 Star Employer Award for 2026

KottonSpa(TM) Debuts World's First Collection of SUPIMA(R) Muslin Baby Essentials.

May 25, 2026, 4:32 AM EDT - 2 months ago

KottonSpa(TM) Debuts World's First Collection of SUPIMA(R) Muslin Baby Essentials.

TM

BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO

May 21, 2026, 5:30 PM EDT - 2 months ago

BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO

Theralase(R) Closes C$4.8 Million Offering

May 20, 2026, 11:06 AM EDT - 2 months ago

Theralase(R) Closes C$4.8 Million Offering

Vera Quinn of Cydcor Named Entrepreneur Of the Year(R) 2026 Greater Los Angeles Finalist by EY US

May 19, 2026, 1:00 PM EDT - 2 months ago

Vera Quinn of Cydcor Named Entrepreneur Of the Year(R) 2026 Greater Los Angeles Finalist by EY US

GMG's THERMAL-XR(R) to be Applied Exclusively & Distributed to Global Oil and Gas/LNG Industry with Curran International

May 19, 2026, 8:05 AM EDT - 2 months ago

GMG's THERMAL-XR(R) to be Applied Exclusively & Distributed to Global Oil and Gas/LNG Industry with Curran International

Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference

May 18, 2026, 2:40 AM EDT - 2 months ago

Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference

Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program

May 13, 2026, 9:00 AM EDT - 2 months ago

Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program

Tenon(R) Medical Reports First Quarter 2026 Financial Results

May 12, 2026, 4:05 PM EDT - 2 months ago

Tenon(R) Medical Reports First Quarter 2026 Financial Results

TNON

Ryder System Transcript: Bank of America’s 33th Annual Industrials, Transportation and Airlines Key Leaders Conference

May 12, 2026, 11:05 AM EDT - 3 months ago

Ryder System Transcript: Bank of America’s 33th Annual Industrials, Transportation and Airlines Key Leaders Conference

BioInvent's TNFR2 Antibody BI-1808 Shows Strong Activity and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026)

May 12, 2026, 10:00 AM EDT - 3 months ago

BioInvent's TNFR2 Antibody BI-1808 Shows Strong Activity and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026)

BioInvent to Present Clinical Data on FcγRIIB Antibody BI-1206 Triplet Combination Therapy with rituximab and Calquence(R) in Relapsed/Refractory NHL at EHA 2026

May 12, 2026, 9:45 AM EDT - 3 months ago

BioInvent to Present Clinical Data on FcγRIIB Antibody BI-1206 Triplet Combination Therapy with rituximab and Calquence(R) in Relapsed/Refractory NHL at EHA 2026

AZN

Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

May 12, 2026, 8:00 AM EDT - 3 months ago

Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

ENSC

Quarterly Report Q1 2026: Orviglance(R) Approaching Transformative Milestones

May 12, 2026, 1:50 AM EDT - 3 months ago

Quarterly Report Q1 2026: Orviglance(R) Approaching Transformative Milestones

Theralase(R) Announces $4 Million Brokered LIFE Offering

May 5, 2026, 7:10 PM EDT - 3 months ago

Theralase(R) Announces $4 Million Brokered LIFE Offering

Ryder CEO to Address Bank of America Securities Industrials, Transportation, and Airlines Key Leaders Conference

May 5, 2026, 6:55 AM EDT - 3 months ago

Ryder CEO to Address Bank of America Securities Industrials, Transportation, and Airlines Key Leaders Conference

Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update

May 4, 2026, 5:22 PM EDT - 3 months ago

Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update

Gelum Shares Approved for Trading on the OTCQB(R) Venture Market

May 4, 2026, 8:00 AM EDT - 3 months ago

Gelum Shares Approved for Trading on the OTCQB(R) Venture Market

AminoQuest Labs(R) Launches New Research Platform and Expands Access to High-Purity Laboratory Peptides

May 1, 2026, 11:13 PM EDT - 3 months ago

AminoQuest Labs(R) Launches New Research Platform and Expands Access to High-Purity Laboratory Peptides

Ryder Declares Quarterly Cash Dividend

May 1, 2026, 4:30 PM EDT - 3 months ago

Ryder Declares Quarterly Cash Dividend

Ryder announces new 2M share repurchase plan

2026-05-01T11:29:21.000Z - 3 months ago

Ryder announces new 2M share repurchase plan

Ryder Authorizes New Discretionary Plan to Repurchase Shares

May 1, 2026, 6:55 AM EDT - 3 months ago

Ryder Authorizes New Discretionary Plan to Repurchase Shares

VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery

Apr 30, 2026, 8:30 AM EDT - 3 months ago

VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery

Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Apr 28, 2026, 8:30 AM EDT - 3 months ago

Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

COCH

Ryder System Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

Ryder System Proxy statement: Proxy filing

SphingoTec Introduces ELISA sphingotest(R) penKid(R) to Enable Broad Kidney Biomarker Testing for Research Applications

Apr 28, 2026, 3:10 AM EDT - 3 months ago

SphingoTec Introduces ELISA sphingotest(R) penKid(R) to Enable Broad Kidney Biomarker Testing for Research Applications

Ryder System Earnings Call Transcript: Q1 2026

Apr 23, 2026, 11:00 AM EDT - 3 months ago

Ryder System Earnings Call Transcript: Q1 2026

Ryder System Earnings release: Q1 2026

Apr 23, 2026, 11:00 AM EDT - 3 months ago

Ryder System Earnings release: Q1 2026

Ryder System Slides: Q1 2026

Apr 23, 2026, 11:00 AM EDT - 3 months ago

Ryder System Slides: Q1 2026

Ryder System Quarterly report: Q1 2026

Apr 23, 2026, 11:00 AM EDT - 3 months ago

Ryder System Quarterly report: Q1 2026

Ryder Reports First Quarter 2026 Results

Apr 23, 2026, 6:55 AM EDT - 3 months ago

Ryder Reports First Quarter 2026 Results

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

Apr 22, 2026, 4:05 PM EDT - 3 months ago

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

CLPT

Ryder Returns to ACT Expo 2026 to Spotlight Advanced Vehicle Technology Solutions & Industry Expertise

Apr 21, 2026, 6:55 AM EDT - 3 months ago

Ryder Returns to ACT Expo 2026 to Spotlight Advanced Vehicle Technology Solutions & Industry Expertise

Estimize
Estimize Jul. 27 at 1:09 PM
Wall St is expecting 4.16 EPS for $R Q3 [Reporting 10/22 BMO] http://www.estimize.com/intro/r?chart=historical&metric_name=eps&utm_content=
0 · Reply
PenkeInvesting
PenkeInvesting Jul. 26 at 3:43 AM
Fundamental analysis of $R (RYDER SYSTEM INC) based on financial data and reported results. #R
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jul. 24 at 1:19 PM
$R Transports steady reepinggg Upgraded to 310 at Susq $CSX $UNP
0 · Reply
EarningsInsider
EarningsInsider Jul. 23 at 4:30 PM
https://www.marketbeat.com/earnings/reports/2026-7-23-ryder-system-inc-stock/ $R Ryder System Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 23 at 11:00 AM
$R Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $3.39 up 6.27% YoY • Reported revenue of $3.35B up 4.95% YoY • Ryder System, Inc. raised its full year 2026 comparable EPS guidance to a range of $14.40 to $14.80, while maintaining its 3% operating revenue growth forecast and free cash flow outlook.
0 · Reply
Estimize
Estimize Jul. 20 at 12:01 PM
Wall St is expecting 3.69 EPS for $R Q2 [Reporting 07/23 BMO] http://www.estimize.com/intro/r?chart=historical&metric_name=eps&utm_content=
0 · Reply
mz08
mz08 Jul. 16 at 4:50 PM
$LIMN $OPEN $MSFT $R
0 · Reply
IN0V8
IN0V8 Jul. 10 at 3:16 PM
$R Citigroup cuts to neutral from buy; ups PT to $280 from $276 JP Morgan raises target price to $259 from $250
0 · Reply
abman54
abman54 Jul. 9 at 2:30 PM
$R push to $275!
0 · Reply
IN0V8
IN0V8 Jul. 8 at 3:37 PM
$R Buy Stephens resumes coverage with overweight rating; target price $310
0 · Reply
Estimize
Estimize Jul. 6 at 12:04 PM
Wall St is expecting 3.66 EPS for $R Q2 [Reporting 07/23 BMO] http://www.estimize.com/intro/r?chart=historical&metric_name=eps&utm_content=
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 4:59 AM
$R Current Stock Price: $265.05 Contracts to trade: $270.0 R Jul 17 2026 Call Entry: $7.47 Exit: $14.36 ROI: 92% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize Jun. 22 at 12:03 PM
Wall St is expecting 3.66 EPS for $R Q2 [Reporting 07/23 BMO] http://www.estimize.com/intro/r?chart=historical&metric_name=eps&utm_content=
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 15 at 7:28 PM
$R Share Price: $277.62 Contract Selected: Nov 20, 2026 $280 Calls Buy Zone: $21.25 – $26.25 Target Zone: $37.43 – $45.74 Potential Upside: 66% ROI Time to Expiration: 157 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
mishari991
mishari991 May. 29 at 12:09 PM
$BBAI $PLTR $R $PL soon will be the story ⌛️⌛️🤌🏼🤌🏼🚀🚀 big bear 🐻 coming
0 · Reply
semiguy
semiguy May. 26 at 10:52 PM
$B $RIGL $RTN $R I told you last week - Magnachip to Showcase MV MOSFET Portfolio for AI Servers and Data Centers Alongside Its Broader Power Semiconductor Portfolio at PCIM Europe 2026 SYMBOL(MX) Magnachip a small cap power solutions semiconductor company based in South Korea. • MKT Cap of $230 million. • Revenue of $180 million. • 8 inch foundry worth approximately 200 million – 36K wafers a month • Cash of $50 million, trading at $5.70 a share. (as of last Friday) • Won’t be at this price for long. Magnachip to Showcase MV MOSFET Portfolio for AI Servers and Data Centers Alongside Its Broader Power Semiconductor Portfolio at PCIM Europe https://www.businesswire.com/news/home/20260526332549/en/Magnachip-to-Showcase-MV-MOSFET-Portfolio-for-AI-Servers-and-Data-Centers-Alongside-Its-Broader-Power-Semiconductor-Portfolio-at-PCIM-Europe-2026
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 14 at 11:36 AM
$R Brilliant piece that captures R's situation perfectly. So if you want to update your understanding of R or get to know R better, this is essential reading. https://everyticker.com/quote/R/analysis/ryder-s-quiet-transformation-how-a-90-year-old-logistics-giant-engineered-a-resilient-platform-with-hidden-cyclical-leverage-nyse-r
0 · Reply
CapitalMonk
CapitalMonk May. 12 at 11:31 PM
$R Price: $227.76 (-2.03%) Trend: Bullish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.00% RSI: 50.1 | Momentum: Moderate Volume: -34.2% vs avg Volatility: 3.18% Support: $209.44 | Resistance: $259.00 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply